CCL2 and lobular neoplasia: Additionally, MCP-1 has shown potential in predicting tubulointerstitial lesions in early stages compared to traditional markers when investigating patients diagnosed with active DN through pathological biopsy analysis involving a cohort consisting of 109 LN patients along with a control group comprising 50 individuals without any kidney abnormalities.